Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 36 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Ranson JM, Kuzma E, Hamilton W, Muniz-Terrera G, Langa KM, Llewellyn DJ. Predictors of dementia misclassification when using brief cognitive assessments. Neurology: Clinical Practice 2018:28 de noviembre. [Ref.ID 102864]
2.Tiene citas relacionadas Cita con resumen
Ogliari G, Sabayan B, Mari D, Rossi PD, Lucchi TA, de Craen AJ, Westendorp RG. Age- and functional status-dependent association between blood pressure and cognition: the Milan Geriatrics 75+ Cohort Study. J Am Geriatr Soc 2015;63:1741-8. [Ref.ID 99561]
3. Cita con resumen
Tsoi KKF, Chan JYC, Hirai HW, Wong SYS, Kwok TCY. Cognitive tests to detect dementia. A systematic review and meta-analysis . JAMA Intern Med 2015;175:1450-8. [Ref.ID 99144]
4. Cita con resumen
Rodda J, Carter J. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia. BMJ 2012;344:43-7. [Ref.ID 92853]
5. Cita con resumen
Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C. Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc 2011;59:111-222. [Ref.ID 90769]
6.Tiene citas relacionadas
Doody R, Seely L, Thomas R, Sano M, Aisen P. Statistical treatment of withdrawal in trials of anti-dementia drugs. Authors' reply. Lancet 2008;372:1383. [Ref.ID 84205]
7.Tiene citas relacionadas
Mackinnon A. Statistical treatment of withdrawal in trials of anti-dementia drugs. Lancet 2008;372:1382-3. [Ref.ID 84204]
8.Tiene citas relacionadas Cita con resumen
Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D, on behalf of the dimebon investigators. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 2008;372:207-15. [Ref.ID 83623]
9.Tiene citas relacionadas
Burns A, Jacoby R. Dimebon in Alzheimer's disease: old drug for new indication. Lancet 2008;372:179-80. [Ref.ID 83617]
10. Cita con resumen
Gilstad JR, Finucane TE. Results, rhetoric, and randomized trials: the case of donepezil. J Am Geriatr Soc 2008;56:1556-62. [Ref.ID 82938]
11. Cita con resumen
Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 2008;148:379-97. [Ref.ID 82315]
12. Cita con resumen
Lechevallier-Michel N, Molimard M, Dartigues JF, Fabrigoule C, Fourrier-Réglat A. Drug with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID study. Br J Clin Pharmacol 2005;59:143-51. [Ref.ID 72902]
13.Tiene citas relacionadas Cita con resumen
14.Tiene citas relacionadas Cita con resumen
Schneider LS. AD2000: donepezil in Alzheimer's disease. Lancet 2004;363:2100-1. [Ref.ID 70557]
15.Tiene citas relacionadas Cita con resumen
Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Dementia and statins. Authors' reply. Lancet 2001;357:880-1. [Ref.ID 55610]
16.Tiene citas relacionadas Cita con resumen
Birkenhäger WH, Wang JG, Staessen JA. Dementia and statins. Lancet 2001;357:880. [Ref.ID 55608]
17.
Bassuk SS, Wypij D, Berkman LF. Cognitive impairment and mortality in the community-dwelling elderly. Am J Epidemiol 2000;151:676-88. [Ref.ID 51028]
18.Tiene citas relacionadas
Bowie P, Branton T, Holmes J. Mini mental state examination. Author's reply. Lancet 2000;355:315. [Ref.ID 49033]
19.Tiene citas relacionadas
Byrne L, Bucks RS, Wilcock GK. Mini mental state examination. Lancet 2000;355:314-5. [Ref.ID 49032]
20. Cita con resumen
Raskind M A, Cyrus PA, Ruzicka B B, Gulanski BI, for the Metrifonate Study Group. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. J Clin Psychiatry 1999;60:318-25. [Ref.ID 47913]
Seleccionar todas
 
 1 a 20 de 36 siguiente >>